Autologous stem cell transplantation for acute lymphocytic leukemia in adults

被引：11

作者：

Martin, TG

Linker, CA

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA

[2] Univ Calif San Francisco, Dept Adult Leukemia & Bone Marrow Transplantat, San Francisco, CA 94143 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2001年 / 15卷 / 01期

关键词：

D O I：

10.1016/S0889-8588(05)70202-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Adults with acute lymphocytic leukemia (ALL) often present with poor prognostic features, and few are cured with standard chemotherapy. High-dose chemoradiotherapy with bone marrow rescue offers potentially curable therapy for many adults with ALL. This article addresses the current role of autologous bone marrow transplantation in adults with ALL. Patient selection, preparative therapy, the timing of transplantation, and the role of purging are reviewed. Future strategies aimed at improving the results of autologous transplantation in ALL are also discussed.

引用

页码：121 / +

页数：24

共 91 条

[51]

JONES R, 1991, LANCET, V9, P754

[52] Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia [J].

Kantarjian, HM ;

O'Brien, S ;

Smith, TL ;

Cortes, J ;

Giles, FJ ;

Beran, M ;

Pierce, S ;

Huh, Y ;

Andreeff, M ;

Koller, C ;

Ha, CS ;

Keating, MJ ;

Murphy, S ;

Freireich, EJ .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :547-561

[53]

KERSEY J, 1992, LEUKEMIA, V6, P191

[54] COMPARISON OF AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR TREATMENT OF HIGH-RISK REFRACTORY ACUTE LYMPHOBLASTIC-LEUKEMIA [J].

KERSEY, JH ;

WEISDORF, D ;

NESBIT, ME ;

LEBIEN, TW ;

WOODS, WG ;

MCGLAVE, PB ;

KIM, T ;

VALLERA, DA ;

GOLDMAN, AI ;

BOSTROM, B ;

HURD, D ;

RAMSAY, NKC .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (08) :461-467

[55]

KLINGEMANN HG, 1991, BLOOD, V78, P3306

[56] INCREASED EFFICACY IN SELECTIVE ELIMINATION OF LEUKEMIC-CELL LINE CLONOGENIC CELLS BY A COMBINATION OF MONOCLONAL-ANTIBODIES BA-1, BA-2, BA-3 + COMPLEMENT AND MAFOSFAMID (ASTA-Z-7557) [J].

LEBIEN, TW ;

ANDERSON, JM ;

VALLERA, DA ;

UCKUN, FM .

LEUKEMIA RESEARCH, 1986, 10 (02) :139-143

[57]

Linker CA, 1999, BLOOD, V94, p580A

[58]

LINKER CA, 1991, BLOOD, V78, P2814

[59]

Linker Charles A., 1997, Leukemia (Basingstoke), V11, pS24

[60] Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells [J].

Margolin, KA ;

Wright, C ;

Forman, SJ .

LEUKEMIA, 1997, 11 (05) :723-728

← 1 2 3 4 5 6 7 8 9 10 →